Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 6,267 | 0.00 | 377,028 |
1 Jan 25 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 31.91 | 11,199 | 357.36 k | 11,199 |
1 Jan 24 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,341 | 0.00 | 370,761 |
1 Jan 24 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 59.86 | 5,748 | 344.08 k | 5,748 |
17 Nov 23 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 47.74 | 1,250 | 59.68 k | 367,420 |
17 Nov 23 | APLS Apellis Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | Yes | 2.67 | 1,250 | 3.34 k | 368,670 |
17 Nov 23 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 2.67 | 1,250 | 3.34 k | 0 |
17 Oct 23 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 48.5 | 1,250 | 60.63 k | 367,420 |
17 Oct 23 | APLS Apellis Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | Yes | 2.67 | 1,250 | 3.34 k | 368,670 |
17 Oct 23 | APLS Apellis Pharmaceuticals | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 2.67 | 1,250 | 3.34 k | 1,250 |